OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-CACNA1D antibodies

Anti-CACNA1D Antibody S48A-9

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA309307 Mouse Monoclonal anti-CACNA1D Antibody 100ug $325 In Stock

Buy any antibody of 100ul or more, get a free package of 3 loading control antibody samples. View Details Add to Shopping Cart

spacer
IF(1)

OriGene Data

ImmunogenFusion protein amino acids 859-875 of rat Cav1.3, accession numbr P27732
Clone NameS48A-9 IsotypeIgG2a
Species ReactivityHuman, Mouse, Rat ConcentrationLot dependent; please refer to CoA along with shipment
Guaranteed Application *IF Suggested DilutionsWB: 1-10ug/ml, IHC: 0.1-1.0ug/ml, IF: 1.0-10ug/ml
BufferPBS pH7.4, 50% glycerol
Note Detects ~250kDa. No cross-reactivity against Cav1.2

Reference Data

Target NameHomo sapiens calcium channel, voltage-dependent, L type, alpha 1D subunit (CACNA1D), transcript variant 1
Alternative NameCACH3; CACN4; CACNL1A2; Cav1.3; CCHL1A2; PASNA; SANDD
Database LinkNP_000711
Entrez Gene 776 Human
Entrez Gene 12289 Mouse
Entrez Gene 29716 Rat
Function
Related PathwayIon Channels: CalciumTransmembraneDruggable Genome MAPK signaling pathwayCalcium signaling pathwayCardiac muscle contractionVascular smooth muscle contractionGnRH signaling pathwayType II diabetes mellitusMore Pathways >>

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

IF detection of Cav1.3 using Anti-Cav1.3 monoclonantibody (TA309307) on human hippocampal tissues.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title